Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Related News

12-Nov-2020 02:58 PM

GSK, Medicago launch trials of Covid-19 vaccine candidate

Pharmaceutical giant GSK and Canadian biopharmaceutical firm Medicago have announced the start of phase 2 and 3 clinical trials of a Covid-19 vaccine candidate. The trials will seek to evaluate the potential vaccine's efficacy, safety and its abilit
09-Nov-2020 08:05 AM

GlaxoSmithKline HIV drug cabotegravir superior to oral standard care

Glaxo's specialist HIV company ViiV Healthcare reported that interim analysis from the HPTN 084 study shows long-acting injectable cabotegravir administered every two months is 89% more effective than daily pills in preventing HIV in women. This fol
28-Oct-2020 01:17 PM

GlaxoSmithKline expects annual earnings at lower end of guidance range

Pharmaceutical company GlaxoSmithKline warned that it expected to post annual earnings at the lower end of its guidance range after its operating profit fell 13% in the third quarter. The company said it expected adjusted earnings per share for the year
28-Oct-2020 12:06 PM

FTSE 100 stabilises but still down more than 1.5% amid Covid fears

FTSE 100 stabilises but still down more than 1.5% amid Covid fears The FTSE 100 was down 1.7% to 5,629.42, off its six-month lows from this morning but still heavily in negative territory as investors weigh news of further national lockdowns across Europ
01-Sep-2020 09:20 AM

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1725p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Aug-2020 09:40 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1800p (from 1920p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 12:00 PM

Broker Forecast - DZ Bank issues a broker note on GlaxoSmithKline PLC

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1850p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 11:50 AM

Broker Forecast - Goldman Sachs issues a broker note on GlaxoSmithKline PLC

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2020p (from 2060p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 08:10 AM

Broker Forecast - Credit Suisse issues a broker note on GlaxoSmithKline PLC

Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1860p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Jul-2020 01:22 PM

GlaxoSmithKline adjusted earnings slump on lower vaccine sales

Pharmaceutical company GlaxoSmithKline said that meeting its annual earnings guidance was contingent on the timing of a recovery in vaccine demand, a slump in which drove a fall in its second-quarter sales. The company reported a more than doubling in pr
22-Jun-2020 12:10 PM

Broker Forecast - Oddo issues a broker note on GlaxoSmithKline PLC

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1840p (from 1760p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-May-2020 10:10 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1920p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
05-May-2020 10:30 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1750p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-May-2020 12:30 PM

Broker Forecast - Goldman Sachs issues a broker note on GlaxoSmithKline PLC

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2060p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-May-2020 03:40 PM

Broker Forecast - DZ Bank issues a broker note on GlaxoSmithKline PLC

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Apr-2020 11:30 AM

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1550p (from 1450p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Apr-2020 01:15 PM

GlaxoSmithKline earnings jump 41% amid Covid-19 drug stockpiling

Pharmaceutical company GlaxoSmithKline posted a 41% jump in first-quarter earnings after drug sales were boosted by stockpiling amid the Covid-19 pandemic. Operating profit for the three months through March increased to £2.01bn, as revenue rose 19
31-Mar-2020 11:20 AM

Broker Forecast - Oddo issues a broker note on GlaxoSmithKline PLC

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1530p (from 1830p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-Mar-2020 08:40 AM

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1450p (from 1550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Mar-2020 11:40 AM

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1725p (from 1740p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
18-Feb-2020 08:30 AM

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1840p (from 1930p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Feb-2020 10:30 AM

Broker Forecast - Societe Generale issues a broker note on GlaxoSmithKline PLC

Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2240p (from 2300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Feb-2020 10:20 AM

Broker Forecast - HSBC issues a broker note on GlaxoSmithKline PLC

HSBC today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2050p (from 2110p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Feb-2020 10:30 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Feb-2020 09:50 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1750p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t